Literature DB >> 8800495

Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers.

H Fickl1, V L Van Antwerpen, G A Richards, D R Van der Westhuyzen, N Davies, R Van der Walt, C A Van der Merwe, R Anderson.   

Abstract

In this study we have measured circulating levels of autoantibodies to cardiolipin and oxidised low-density lipoprotein (ox-LDL) and correlated these with plasma concentrations of the anti-oxidant nutrients vitamin C, vitamin E and beta-carotene, in a group (79) of asymptomatic, male cigarette smokers and in non-smoking control subjects. Cigarette smoking, a well-known risk factor for development of atherosclerosis, was found to be associated with moderately elevated levels of autoantibodies to both cardiolipin and ox-LDL. Increased levels of these autoantibodies were most evident in the older smokers (> 30 years) and were significantly and inversely correlated with plasma vitamin C, but not with vitamin E or beta-carotene. Absorption studies designed to investigate the specificity of these autoantibodies demonstrated a high degree of cross-reactivity of cardiolipin antibodies with ox-LDL, while antibodies to the oxidatively modified lipoprotein tended to be specific for this antigen. These findings suggest that cigarette smoking promotes formation of autoantibodies to both cardiolipin and ox-LDL and that these may be involved in the initiation and/or perpetuation of atherosclerosis. Dietary intake of vitamin C may be a determinant of susceptibility to development of this cardiovascular disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800495     DOI: 10.1016/0021-9150(96)05820-0

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

1.  (-)-Epigallocatechin-gallate (EGCG) stabilize the mitochondrial enzymes and inhibits the apoptosis in cigarette smoke-induced myocardial dysfunction in rats.

Authors:  Gokulakrishnan Adikesavan; Magendira Mani Vinayagam; Liyakath Ali Abdulrahman; Thirunavukkarasu Chinnasamy
Journal:  Mol Biol Rep       Date:  2013-11-07       Impact factor: 2.316

2.  The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-beta2-glycoprotein I antibodies.

Authors:  C Neville; J Rauch; J Kassis; S Solymoss; L Joseph; P Belisle; R Subang; E R Chang; P R Fortin
Journal:  Rheumatology (Oxford)       Date:  2006-03-01       Impact factor: 7.580

Review 3.  Anti-phospholipid Antibodies and Smoking: An Overview.

Authors:  Steven R Binder; Christine M Litwin
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

4.  An Evaluation of the Clinical Evidence on the Role of Inflammation and Oxidative Stress in Smoking-Mediated Cardiovascular Disease.

Authors:  Adam Csordas; Georg Wick; Günther Laufer; David Bernhard
Journal:  Biomark Insights       Date:  2008-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.